BFG
FTXH icon

Beto Financial Group’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History

Beto Financial Group’s Portfolio FTXH Stock Details FTXH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$260K Hold
6,833
– – 0.14% 134
2026
Q1 		$232K Buy
+6,833
New +$233K 0.14% 134

Other funds holding FTXH

LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Oppenheimer & Co
Oppenheimer & Co New York $9.37B AUM 36.4% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
MIM
Marshall Investment Management Littleton, Colorado $241M AUM 30.53% 1-Year Est. Return
Ameritas Investment Partners
Ameritas Investment Partners Lincoln, Nebraska $3.75B AUM 46.53% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
NP
Nilsine Partners Greenwood Village, Colorado $1.45B AUM 47.06% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Beto Financial Group's FTXH Position: Q2 2026 in Review

Beto Financial Group held its First Trust Nasdaq Pharmaceuticals ETF (FTXH) position steady in Q2 2026 at 6,833 shares worth $260K. The position accounts for 0.14% of the portfolio, ranked #134.

Beto Financial Group first reported a position in FTXH in Q1 2026 and has held it in 2 quarters since. 30 funds tracked by Wall St. Rank hold FTXH as of Q2 2026.

  • Beto Financial Group held 6,833 shares of First Trust Nasdaq Pharmaceuticals ETF worth $260K as of Q2 2026.
  • Beto Financial Group left its First Trust Nasdaq Pharmaceuticals ETF share count unchanged in Q2 2026.
  • First Trust Nasdaq Pharmaceuticals ETF made up 0.14% of Beto Financial Group's portfolio in Q2 2026, its #134 holding.
  • Beto Financial Group first reported a position in First Trust Nasdaq Pharmaceuticals ETF in Q1 2026 and has held it in 2 quarters since.
  • 30 funds tracked by Wall St. Rank held First Trust Nasdaq Pharmaceuticals ETF as of Q2 2026.

Based on Beto Financial Group's 13F filing for Q2 2026, filed 7 Aug 2026.